Telmisartan Inhibits Cell Proliferation and Tumor Growth of Esophageal Squamous Cell Carcinoma by Inducing S-Phase Arrest In Vitro and In Vivo

Esophageal squamous cell carcinoma (ESCC) is the most common primary esophageal malignancy. Telmisartan, an angiotensin II type 1 (AT1) receptor blocker (ARB) and a widely used antihypertensive, has been shown to inhibit proliferation of various cancer types. This study evaluated the effects of telm...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsui, Takanori, Chiyo, Taiga, Kobara, Hideki, Fujihara, Shintaro, Fujita, Koji, Namima, Daisuke, Nakahara, Mai, Kobayashi, Nobuya, Nishiyama, Noriko, Yachida, Tatsuo, Morishita, Asahiro, Iwama, Hisakazu, Masaki, Tsutomu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6651359/
https://www.ncbi.nlm.nih.gov/pubmed/31261874
http://dx.doi.org/10.3390/ijms20133197

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6651359/
https://www.ncbi.nlm.nih.gov/pubmed/31261874
http://dx.doi.org/10.3390/ijms20133197

Ejemplares similares